Introduction Thromboprophylaxis is highly effective, safe and cost-effective. However, data
from international studies have shown that many at-risk hospitalised patients do not receive …

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the UK.
Studies have shown that pulmonary embolism causes or contributes to approximately 1 in …

Venous thromboembolism in adults is related to recent hospitalisation in approximately half
of all cases and approximately half of all hospitalised adult patients are considered to be at …

Background Venous thromboembolism (VTE) is relatively common among hospitalized
patients, is often clinically silent, and is associated with substantial morbidity and mortality …

Venous thromboembolism (VTE) is a major cause of morbidity and mortality in hospitalised
patients. Thromboprophylaxis is an effective strategy for VTE prevention in high‐risk …

BACKGROUND: Venous thromboembolism (VTE) prophylaxis in acutely ill medical patients
has been shown to be safe and effective. Underutilization of this patient safety practice may …

We prospectively assessed the implementation of venous thromboembolism (VTE)
prophylaxis guidelines and the impact of grand round presentation of the data in changing …

BACKGROUND AND OBJECTIVES: Evidence-based international guidelines recommend
that all patients undergoing elective hip or knee arthroplasty receive thromboprophylaxis …

Historically, hospital-related venous thromboembolism (VTE) has been thought to mainly
occur in surgical patients (1). Several phase III randomised controlled trials (RCTs) have …

Objectives: To measure eligibility for medical thromboprophylaxis using two Australasian
guidelines—the Australia and New Zealand Working Party Guidelines [WPG] and the …